82382-3
Sofosbuvir [Susceptibility] by Genotype method
Active
Term Description
An interpretation of "resistance predicted" suggests that treatment failure with sofosbuvir may be due to the presence of an NS5B mutation (S282T). An interpretation of "resistance not predicted" indicates that the S282T sofosbuvir resistance mutation was not detected.
Part Description
LP220265-5 Sofosbuvir
Sofosbuvir (Sovaldi) is a nucleotide analogue NS5B polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection as a component of a combination antiviral treatment regimen. The replication of HCV requires NS5B, an RNA-dependent RNA polymerase, responsible for the synthesis of both positive-strand genomic RNA and negative-strand RNA. Sofosbuvir mimics the natural substrate of NS5B polymerase and becomes incorporated into the growing RNA, inducing a chain termination event. Sofosbuvir, as one of the nucleos(t)ide analog inhibitors, has a distinct resistance profile that does not overlap with the non-nucleoside NS5B protease inhibitors. Resistance to sofosbuvir is uncommon. The S282T mutation has been identified as the common variant to pose resistance to sofosbuvir, however, this variant is not generally found in untreated patients with HCV. PMID: 24883006
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Sofosbuvir:
Susc: Pt: Isolate: Ord: Genotyping - Long Common Name
- Sofosbuvir [Susceptibility] by Genotype method
- Short Name
- Sofosbuvir Islt Genotyp
- Display Name
- Sofosbuvir Genotyping [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Sofosbuvir
Part Model Get Info
- Component
- Sofosbuvir
LP220265-5
- Analyte
- Sofosbuvir
LP220265-5
- Component Numerator
- Sofosbuvir
LP220265-5
- Component Numerator Core
- Sofosbuvir
LP220265-5
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Susc
LP6870-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Isolate
LP7370-2
- System Core
- Isolate
LP7370-2
- Super System
- NULL
- Scale
- Ord
LP7751-3
- Method
- Genotyping
LP28723-2
Example Answer List: LL4039-5
Source: Quest Diagnostics Inc.| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Resistance predicted | LA26373-3 | ||
| Resistance not predicted | LA26374-1 |
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.58
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 15627
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Sofosbuvir: |
| el-GR | Greek (Greece) | Σοφοσμπουβίρη: Synonyms: ABXBACT Ord Pt Susc Απομονωμένο στέλεχος Γονοτύπηση Σοφοσμπουβίρη |
| es-ES | Spanish (Spain) | Sofosbuvir: |
| es-MX | Spanish (Mexico) | Sofosbuvir: |
| fr-FR | French (France) | Sofosbuvir: |
| it-IT | Italian (Italy) | Sofosbuvir: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità al genotipo virale |
| nl-NL | Dutch (Netherlands) | sofosbuvir: |
| pl-PL | Polish (Poland) | Sofosbuwir: Synonyms: wrażliwość (mikroorganizmów) |
| zh-CN | Chinese (China) | 索非布韦: Synonyms: 依次型; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://